Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 2/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11305111 | 1.00 | BTN3A1 (0.33) | BTN3A1FDPSBLMTDP1MPI | |
| SCHEMBL29512271 | 1.00 | BTN3A1 (0.33) | BTN3A1FDPSBLMTDP1MPI | |
| SCHEMBL9698100 | 1.00 | BTN3A1 (0.33) | BTN3A1FDPSBLMTDP1MPI | |
| Guanidine SCHEMBL9485722 | 0.92 | — | — | |
| SCHEMBL1976284 | 0.87 | MPI (0.33) | MPI | |
| SCHEMBL7715581 | 0.87 | MPI (0.33) | MPI | |
| SCHEMBL7715583 | 0.87 | MPI (0.33) | MPI | |
| SCHEMBL6386404 | 0.81 | MPI (0.34) | MPI | |
| SCHEMBL3492399 | 0.79 | PGD (0.36) | — | |
| SCHEMBL4082207 | 0.79 | LMNA (0.37) | BTN3A1TDP1MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7214517-B2 | α1,2-fucosyltransferase and DNA encoding the same | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-05-08 | — | — | US | claimed |
| EP-0642526-B1 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE | SCRIPPS RESEARCH INST (US) | 1998-12-23 | — | — | EP | claimed |
| US-20260042866-A1 | METHODS OF MAKING FUCOSYLATED AND AFUCOSYLATED FORMS OF A PROTEIN | GENENTECH, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-12391769-B2 | Methods of making fucosylated and afucosylated forms of a protein | GENENTECH, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| EP-4541815-A1 | ANTIBODY AGAINST HEPATITIS B VIRUS, PREPARATION THEREOF AND USE THEREOF | Huahui Health Ltd. (CN) | 2025-04-23 | — | — | EP | disclosed |
| US-20240158536-A1 | METHODS OF MAKING FUCOSYLATED AND AFUCOSYLATED FORMS OF A PROTEIN | GENENTECH, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-11802165-B2 | Methods of making fucosylated and afucosylated forms of a protein | GENENTECH, INC. (US) | 2023-10-31 | — | — | US | disclosed |
| EP-2271669-A1 | ANTIBODIES WITH ENHANCED ADCC FUNCTION | Genentech, Inc. (US) | 2011-01-12 | — | — | EP | disclosed |
| WO-2009114641-A1 | ANTIBODIES WITH ENHANCED ADCC FUNCTION | GENENTECH, INC. (US) | 2009-09-17 | — | — | WO | disclosed |
| US-7335500-B2 | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-02-26 | — | — | US | disclosed |
| US-20020068331-A1 | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose | WONG CHI-HUEY (US) | 2002-06-06 | — | — | US | disclosed |
| US-6319695-B1 | FORMING A GLYCOSIDE BOND BY ETHERIFICATION AND CIRCULATION | THE SCRIPPS RESEARCH INSITUTE | 2001-11-20 | — | — | US | disclosed |
| EP-0642526-B1 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE | SCRIPPS RESEARCH INST (US) | 1998-12-23 | — | — | EP | disclosed |
| EP-0642526-A4 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE. | SCRIPPS RESEARCH INST (US) | 1996-04-10 | — | — | EP | disclosed |
| EP-0642526-A1 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-03-15 | — | — | EP | disclosed |
| WO-1993008205-A1 | PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042866-A1 | METHODS OF MAKING FUCOSYLATED AND AFUCOSYLATED FORMS OF A PROTEIN | FCGR2A, FCER2, FCGR3B | BTN3A1 4357/4885FDPS 394/4885BLM 4733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.